2-(dimethylamino)ethyl methacrylate and Cancer of Colon

2-(dimethylamino)ethyl methacrylate has been researched along with Cancer of Colon in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abedi, F; Akbarzadeh, A; Baradaran, B; Davaran, S; Hekmati, M; Moghaddam, SV	1

Other Studies

1 other study(ies) available for 2-(dimethylamino)ethyl methacrylate and Cancer of Colon

Article	Year
An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells. Journal of nanobiotechnology, 2021, Jan-09, Volume: 19, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Curcumin; Doxorubicin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Therapy, Combination; HT29 Cells; Humans; Hydrogen-Ion Concentration; Methacrylates; Nanogels; Nanoparticles; Particle Size	2021

Article

Year

An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells.

Journal of nanobiotechnology, 2021, Jan-09, Volume: 19, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Curcumin; Doxorubicin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Therapy, Combination; HT29 Cells; Humans; Hydrogen-Ion Concentration; Methacrylates; Nanogels; Nanoparticles; Particle Size

2021